NOVA.F - Novo Nordisk A/S

Frankfurt - Frankfurt Delayed Price. Currency in EUR
56.50
0.00 (0.00%)
As of 6:16PM CEST. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close56.50
Open57.00
Bid57.00 x 100000
Ask57.50 x 100000
Day's Range56.50 - 57.50
52 Week Range42.20 - 61.00
Volume31
Avg. Volume148
Market Cap134.889B
Beta (5Y Monthly)0.41
PE Ratio (TTM)22.95
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.45 (2.54%)
Ex-Dividend DateMar 27, 2020
1y Target EstN/A
All
News
Press Releases
  • Novo Nordisk offers free 90-day insulin supply to people experiencing financial hardship due to COVID-19
    PR Newswire

    Novo Nordisk offers free 90-day insulin supply to people experiencing financial hardship due to COVID-19

    People with diabetes using Novo Nordisk Inc. insulin who have lost health insurance coverage because of a change in job status due to the COVID-19 pandemic may now be eligible for enrollment in our Diabetes Patient Assistance Program (PAP) and receive insulin free of charge for 90 days.

  • Coronavirus (COVID-19) resources available from Novo Nordisk in the US
    PR Newswire

    Coronavirus (COVID-19) resources available from Novo Nordisk in the US

    We recognize that people with chronic diseases, including diabetes, obesity and hemophilia, are at increased risk during this pandemic and Novo Nordisk is taking measures to support the communities we serve throughout the COVID-19 pandemic.

  • Novo Nordisk's new insulin affordability offerings now available in the US
    PR Newswire

    Novo Nordisk's new insulin affordability offerings now available in the US

    Today, Novo Nordisk launched the My$99Insulin Program, follow-on brands of insulins, and an Immediate Supply option, expanding its insulin affordability offering to help people with diabetes who need alternative solutions. These options, along with information on the existing patient assistance program, copay cards, and where to find $25/vial human insulin, are now available online at NovoCare.com or by calling 1.844.NOVO4ME (1.844.668.6463).